Scientist shares reversal of liver disease in new trial

Name: Scientist shares reversal of liver disease in new trial
Uploaded: 2025-05-03T02:43:47Z
Duration: 5 min 19 s
Description: Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the clinical trial involving 800 participants, in which a weekly dose of semaglutide was effective at treating fatty liver disease.

FNC · Aired May 3, 2025 · 5m 19s

Watch Now

Already a subscriber?

Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, discusses the clinical trial involving 800 participants, in which a weekly dose of semaglutide was effective at treating fatty liver disease.